Veracyte | VCYT - Créances Commerciales





Créances Commerciales Changement Date
Agenus USD 22.34M 107K 2026-03
Agilent USD 1.48B 20M 2026-06
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 8.56M 7.13M 2026-06
Bruker USD 545.9M 3.2M 2026-06
Heron Therapeutics USD 89.59M 8.54M 2025-12
Illumina USD 764M 26M 2026-06
Intrexon USD 1.02M 559K 2024-06
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
Laboratory Of America USD 2.5B 54.3M 2026-06
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
Myriad Genetics USD 115.3M 2.7M 2025-12
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sangamo BioSciences USD 581K 110K 2024-06
Siemens EUR 28.59B 484M 2026-06
Sonic Healthcare AUD 1.39B 23.76M 2024-12
Thermo Fisher Scientific USD 9.45B 247M 2026-06
Veracyte USD 54.18M 4.06M 2026-06
Waters USD 1.99B 228M 2026-06